Cargando…
Safety and Accuracy of Sentinel Lymph Node Biopsy Alone in Clinically Node-Positive Patients Undergoing Upfront Surgery for Invasive Breast Cancer: A Systematic Review
Landmark trials (Z0011 and AMAROS) have demonstrated that axillary lymph node dissection (ALND) can be safely omitted in patients with breast cancer and 1–2 positive sentinel nodes. Extrapolating from these and other cardinal studies such as NSABP B-04, guidelines state that patients with 1–2 needle...
Autores principales: | Lovrics, Olivia, Tao, Brendan, Parvez, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047769/ https://www.ncbi.nlm.nih.gov/pubmed/36975448 http://dx.doi.org/10.3390/curroncol30030235 |
Ejemplares similares
-
Accuracy of sentinel node mapping in patients with biopsy-proven metastatic axillary lymph nodes and upfront surgery: preliminary results of the Multimodal Targeted Axillary Surgery (MUTAS) trial
por: Vernet-Tomás, Maria, et al.
Publicado: (2023) -
Sentinel Lymph Node Biopsy and Complete Lymph Node Dissection for Melanoma
por: Falk Delgado, Alberto, et al.
Publicado: (2019) -
Efficacy of sentinel lymph node biopsy with radioisotope alone and the prediction of sentinel node status using PET-CT in breast cancer
por: Song, Ran, et al.
Publicado: (2021) -
The Role and Necessity of Sentinel Lymph Node Biopsy for Invasive Melanoma
por: Nakamura, Yasuhiro
Publicado: (2019) -
Network meta‐analysis of novel and conventional sentinel lymph node biopsy techniques in breast cancer
por: Mok, C. W., et al.
Publicado: (2019)